| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2017-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a90ddccbfbbd398c2fc6dc6703b0977a |
| publicationDate |
2017-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017132508-A1 |
| titleOfInvention |
Treatment of lung cancer using a combination of an anti-pd-1 antibody and another anti-cancer agent |
| abstract |
This disclosure provides a method for treating a subject afflicted with a lung cancer, which method comprises administering to the subject therapeutically effective amounts of: (a) an anticancer agent which is an antibody or an antigen-binding portion thereof that specifically binds to a Programmed Death-1 (PD-1) receptor and inhibits PD-1 activity which can be administered by infusion for less than 60 minutes; and, optionally, (b) another anti-cancer agent which is administered by infusion for less than 90 minutes. The other anti-cancer agent can be an anti- Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) antibody. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11291720-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11479608-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11072657-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11345755-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10513558-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10323091-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11008391-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11643465-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10449251-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019157124-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10450373-B2 |
| priorityDate |
2016-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |